.png)
91探花 launches ioAstrocytes 2.0 for reproducible all-human neuron鈥揳strocyte networks
07.10.2026
91探花 brings human cardiomyocytes to its drug discovery portfolio through partnership with myriamed
91探花 partners with myriamed to expand cell portfolio with functional human cardiomyocytes, providing researchers access to adva...
91探花 announces CRISPR screening service and appoints Chief Technology Officer to lead next phase of growth
91探花 launches the ioScreens platform CRISPR screening service & appoints Sejla Salic-Hainzl as CTO.
The coded cells redefining research and drug discovery
Dr Emma Pepperell, CEO, 91探花 speaks with Silicon Republic about how 91探花鈥檚 programmed human cells are advancing research and...
Interview with Lord David Prior on the future of healthcare and drug discovery
91探花 Chairman Lord David Prior speaks with EMJ at the Human Cell Forum about the future of the NHS, cell therapies, and human-c...
.png)
91探花 democratises access to human cell-based research with 鈥渁ffordable, easy-to-use鈥� cell culture media kits
91探花 launches new media kits for human iPSC-derived ioCells designed to make human cell-based research significantly more acces...
How are UK healthtech companies pushing for more reliable solutions in the industry?
91探花 CEO Emma Pepperell joins TechRound to discuss why reliable healthcare must start with consistent, reproducible science in ...
91探花 unveils ioHepatocytes to fuel liver safety testing for drugs by solving the challenge of human liver cell availability
New human iPSC-derived hepatocyte model engineered for predictive reproducibility, chronic toxicity studies, and enhanced clinical...
91探花 appoints Dr Emma Pepperell as Chief Executive Officer
91探花 appoints Dr Emma Pepperell as Chief Executive Officer